Taxa Technologies is focused on addressing the complex challenges associated with engineering the human microbiome. The company recognizes the difficulty in reliably recoding genes within this intricate ecosystem, which has historically posed significant obstacles for researchers. By inviting innovative scientists to collaborate, Taxa aims to develop solutions that can effectively manipulate and enhance the microbiome, potentially leading to breakthroughs in health and disease management.

In addition to its commitment to advancing microbiome engineering, Taxa Technologies is actively working on a pipeline of products that leverage its scientific insights. The company is dedicated to exploring novel approaches and technologies that can facilitate the understanding and application of microbiome science. Through its research and development efforts, Taxa seeks to create impactful solutions that harness the power of the microbiome for therapeutic purposes, ultimately contributing to improved health outcomes.

United States

Taxa Technologies is a probiotics company that aims to revolutionize the understanding of microbiome engineering. They are focused on designing probiotics for personal care and enabling cheaper, faster, and better genetic engineering.

Taxa Technologies

Company Details